PHASE-III TRIAL; GROWTH-FACTOR RECEPTOR; 3-KINASE INHIBITOR; IN-VITRO; KAPPA-B; CELLS; APOPTOSIS; PATHWAY; AKT; ERLOTINIB
INTERNATIONAL JOURNAL OF ONCOLOGY, v.45, no.1, pp.311 - 321
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.